Changeflow GovPing Healthcare & Life Sciences NIH Registers PMCF Study for Tears Naturale Eye...
Routine Notice Added Final

NIH Registers PMCF Study for Tears Naturale Eye Drops

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH has registered a post-market clinical follow-up (PMCF) study (NCT07540884) evaluating the effectiveness and safety of Tears Naturale Free and Tears Naturale II lubricant eye drops in subjects with dry eye disease. The study will assess both products as lubricating eye drop interventions. This is a clinical trial registration entry on ClinicalTrials.gov, providing public access to study details and recruitment information.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH registered a new post-market clinical follow-up study on ClinicalTrials.gov for Tears Naturale Free and Tears Naturale II lubricant eye drops. The study aims to describe the effectiveness and safety of these over-the-counter lubricating eye drops in subjects experiencing dry eye disease symptoms.

Affected parties include pharmaceutical manufacturers marketing lubricant eye drops, clinical investigators conducting ophthalmic research, and healthcare providers prescribing dry eye treatments. As a clinical trial registration record, this document does not impose compliance obligations but provides transparency into ongoing post-market safety surveillance for these products.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops

N/A NCT07540884 Kind: NA Apr 21, 2026

Abstract

The purpose of this post-market clinical follow-up (PMCF) study is to describe the effectiveness and safety of Tears Naturale® Free and Tears Naturale® II lubricant eye drops in subjects experiencing dry eye (DE) symptoms.

Conditions: Dry Eye Disease

Interventions: Tears Naturale Free lubricating eye drops, Tears Naturale II lubricating eye drops

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Clinical investigators Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Clinical trial registration Post-market surveillance Ophthalmic drug evaluation
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Clinical Operations
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!